Literature review on the immunogenicity of herpes zoster vaccines .: HP40-243/2018E-PDF

"Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This zoster vaccine immunogenicity review was done to have a comprehensive understanding of the immunogenicity of both live and subunit vaccines"--Executive summary, p. 3.

Permanent link to this Catalogue record:
http://publications.gc.ca/pub?id=9.865656&sl=0

Publication information
Department/Agency Canada. Public Health Agency of Canada.
Title Literature review on the immunogenicity of herpes zoster vaccines .
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Revue de la littérature sur l'immunogénicité des vaccins contre le zona.
"Publication date: January 2019."
"An Advisory Committee Review (ACR), National Advisory Committee on Immunization (NACI)."
Cover title.
Includes bibliographical references.
Publishing information [Ottawa] : Public Health Agency of Canada, 2019.
Description 46 p.
ISBN 9780660288628
Catalogue number
  • HP40-243/2018E-PDF
Departmental catalogue number Pub. : 180582
Subject terms Immunization
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: